Precautions and warnings

Pregnancy. Long-term treatment might cause numbness, prickling, or formication in the lower limbs, which can lead to treatment discontinuation in rare circumstances.

Drug Interactions

Other almitrine-containing products should not be used at the same time. MAOIs have the potential to be fatal.

Contraindications

Concurrent usage with MAOIs.

Mode of actions

By boosting the oxygen content of arterial blood, almitrine and raubasine work synergistically to enhance the quantity of oxygen delivered to the brain and neurosensory tissue.

Dosage & Administration

Adult: PO Auditory, vestibular and visual disorders of ischaemic aetiology; Cerebrovascular insufficiency; Functional rehabilitation after cerebrovascular accidents Per tab contains almitrine 30 mg and raubasine 10 mg: 1 tab twice daily.

Pregnancy & Lactation

FDA has not yet classified this medicine into a specified pregnancy category. Although there is no enough evidence that taking this medicine during you are pregnant is harmful.

Discuss with your doctor if you are trying to get pregnant while taking this medicine too.

If you do become pregnant while you are taking this medicine, you should continue to take it and contact with your doctors as quickly as possible. They can assist you to decide whether or not to keep taking this medicine. If you abandon taking this medicine and become sick, this would be more pernicious to your child than staying on the medication.


There is no specific information about whether this medicine is passed on to the baby through breast milk. During this medication, if your baby becomes very sleepy, restless, fatigued, exhibit feeding problems, stop breastfeeding and talk to your doctors very quickly.

Pack Size & Price